Macleods Pharmaceuticals Limited v. M/S.Apex Laboratories Pvt. Ltd.

A. No.6355 of 2023 in C.S. No.232 of 2020 A. No.6355 of 2023 in C.S. No.232 of 2020 ABDUL QUDDHOSE,J.

This application has been filed to file a rejoinder cum reply statement to the reply cum written statement filed by the plaintiff to the written statement cum counter claim filed by the defendant in the suit. 2.As seen from the affidavit filed in support of this application, a counter claim has been filed by the applicant/defendant and a reply statement has already been filed by the plaintiff to the said counter claim and written statement. The defendant seems to be aggrieved by certain pleadings made in the reply statement filed by the plaintiff to the written statement cum counter claim. 3.Learned counsel for the respondent/plaintiff has raised objection for allowing this application.

4.However, this Court is of the considered view that no prejudice would be caused to the respondent/plaintiff if this application is allowed without prejudice to the rights and contentions of the respondent/plaintiff in the main suit with regard to the averments contained in the affidavit filed in support of this https://www.mhc.tn.gov.in/judis 1/2

A. No.6355 of 2023 in C.S. No.232 of 2020 application.

ABDUL QUDDHOSE,J.

vga 5.For the foregoing reasons, this application is allowed as prayed for, without prejudice to the rights and contentions of the respondent/plaintiff with regard to the averments contained in the affidavit filed in support of this application.

Post the matter for Case Management Hearing on 06.12.2023. 29.11.2023 vga A. No.6355 of 2023 in C.S. No.232 of 2020 https://www.mhc.tn.gov.in/judis 2/2